CRISPR Therapeutics
CRSP
$56.99
Share price
-4.47%
Change (1 day)
-46.94%
Change (1 year)
Market capitalization of CRISPR Therapeutics (CRSP)
Market cap: NZ$4.88 Billion
As of April 2025 CRISPR Therapeutics has a market cap of NZ$4.88 Billion. This makes CRISPR Therapeutics the world's 3554th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of CRISPR Therapeutics from 2016 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | NZ$4.88 B | -19.29% |
| 2024 | NZ$6.05 B | -22.97% |
| 2023 | NZ$7.86 B | 56.85% |
| 2022 | NZ$5.01 B | -40.96% |
| 2021 | NZ$8.49 B | -43.81% |
| 2020 | NZ$15.11 B | 174.88% |
| 2019 | NZ$5.49 B | 148.89% |
| 2018 | NZ$2.20 B | 65.95% |
| 2017 | NZ$1.33 B | 14.3% |
| 2016 | NZ$1.16 B |
End of Day market cap according to different sources
On Apr 3rd, 2025 the market cap of CRISPR Therapeutics was reported to be:
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | NZ$0.65 B | -86.66% | 🇺🇸 USA |